Switch to:
More From Other Websites
Big Pharma partners with another Bay Area company in cancer immunotherapy quest Sep 27 2016
NEKTAR THERAPEUTICS Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD... Sep 27 2016
Nektar Therapeutics to Host Investor & Analyst Conference Call to Discuss New Clinical Collaboration... Sep 27 2016
Bristol-Myers to test Opdivo with Nektar drug for several cancers Sep 27 2016
Bristol-Myers Squibb and Nektar Therapeutics Announce Oncology Clinical Collaboration to Evaluate... Sep 27 2016
Bristol, Nektar Research Pact Aims to Boost Efficacy of Cancer Immunotherapy Sep 27 2016
7:00 am Nektar Therapeutics announces a collaboration to evaluate Bristol-Myers Squibb's (Sep 27 2016
Bristol-Myers Squibb and Nektar Therapeutics Announce Oncology Clinical Collaboration to Evaluate... Sep 27 2016
The opioids of the future won't get you high Sep 18 2016
4 stocks to watch Sep 14 2016
Two Californian research teams are on the path to ending the opioid crisis — and their drugs have... Sep 13 2016
Nektar And Three Other Momentum Stocks With Bullish Charts Sep 08 2016
[$$] Two Biotech CEOs Make $1M Stock Sales Sep 08 2016
4 stocks to watch Sep 07 2016
Mobileye And Three More Stocks Breaking Out Aug 24 2016
ETF’s with exposure to Nektar Therapeutics : August 22, 2016 Aug 22 2016
NEKTAR THERAPEUTICS Financials Aug 12 2016
ETF’s with exposure to Nektar Therapeutics : August 11, 2016 Aug 11 2016
Nektar Therapeutics :NKTR-US: Earnings Analysis: Q2, 2016 By the Numbers : August 8, 2016 Aug 08 2016
[$$] Nektar Therapeutics' Sweet Pipeline Aug 05 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK